Format

Send to

Choose Destination
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3316-3326. doi: 10.1210/jc.2016-4014.

A Role for Progesterone-Regulated sFRP4 Expression in Uterine Leiomyomas.

Author information

1
Department of Obstetrics & Gynecology, Baylor College of Medicine, Houston, Texas 77030.
2
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030.
3
Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas 77030.
4
Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas 77030.
5
Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030.

Abstract

Context:

Despite progesterone's key role in uterine smooth muscle tumorigenesis, the mechanisms by which it promotes the growth of uterine leiomyomas remain poorly understood.

Objective:

The aim of this study was to identify gene products mediating the effects of progesterone in uterine leiomyomas.

Design:

Gene expression profiling was used to identify putative progesterone-regulated genes differentially expressed in uterine leiomyomas, which were then studied in vitro.

Methods:

Gene expression was comprehensively profiled with the Illumina WG BeadChip (version 2.6) and analyzed with a bioinformatic algorithm that integrates known protein-protein interactions. Genomic binding sites for progesterone receptor (PR) were interrogated by chromatin immunoprecipitation-quantitative polymerase chain reaction (ChIP-qPCR). Small interfering RNA was used to study gene function in primary cell lines.

Results:

Our analyses identified secreted Frizzled-related protein 4 (sFRP4) as a key gene product functionally linked to PR activation whose expression was 2.6 times higher in leiomyomas than myometrium (n = 26, P < 0.01) and 2.5 times higher during the proliferative phase of the menstrual cycle (n = 26, P < 0.01). Direct binding between PR and sFRP4 promoter was observed by ChIP-qPCR. Robust overexpression of sFRP4 was also observed in primary cultures derived from leiomyoma. Progesterone preferentially inhibited sFRP4 expression and secretion in leiomyoma cultures in a dose-dependent manner sensitized by estradiol. Knockdown of sFRP4 inhibited proliferation and apoptosis in primary cultures of both myometrium and leiomyoma.

Conclusions:

Overexpression of sFRP4 is a robust, progesterone-regulated feature of leiomyomas that increases smooth muscle proliferation. More work is needed to elucidate how progesterone's ability to modulate sFRP4 expression contributes to uterine smooth muscle tumorigenesis.

PMID:
28637297
PMCID:
PMC5587057
DOI:
10.1210/jc.2016-4014
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center